このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Aarti Drugs バランスシートの健全性
財務の健全性 基準チェック /56
Aarti Drugsの総株主資本は₹12.8B 、総負債は₹5.6Bで、負債比率は44%となります。総資産と総負債はそれぞれ₹24.3Bと₹11.5Bです。 Aarti Drugsの EBIT は₹2.5Bで、利息カバレッジ比率7.4です。現金および短期投資は₹207.7Mです。
主要情報
44.0%
負債資本比率
₹5.64b
負債
| インタレスト・カバレッジ・レシオ | 7.4x |
| 現金 | ₹207.70m |
| エクイティ | ₹12.82b |
| 負債合計 | ₹11.50b |
| 総資産 | ₹24.32b |
財務の健全性に関する最新情報
Aarti Drugs (NSE:AARTIDRUGS) Has A Somewhat Strained Balance Sheet
Sep 05
Is Aarti Drugs (NSE:AARTIDRUGS) A Risky Investment?
May 04These 4 Measures Indicate That Aarti Drugs (NSE:AARTIDRUGS) Is Using Debt Reasonably Well
Nov 22Does Aarti Drugs (NSE:AARTIDRUGS) Have A Healthy Balance Sheet?
Mar 17Aarti Drugs (NSE:AARTIDRUGS) Seems To Use Debt Quite Sensibly
Dec 08Recent updates
We Discuss Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Sep 20Aarti Drugs (NSE:AARTIDRUGS) Has A Somewhat Strained Balance Sheet
Sep 05Is Aarti Drugs (NSE:AARTIDRUGS) A Risky Investment?
May 04Aarti Drugs Limited Recorded A 9.0% Miss On Revenue: Analysts Are Revisiting Their Models
Feb 01Aarti Drugs (NSE:AARTIDRUGS) Is Due To Pay A Dividend Of ₹1.00
Jan 30Aarti Drugs' (NSE:AARTIDRUGS) Anemic Earnings Might Be Worse Than You Think
May 17These 4 Measures Indicate That Aarti Drugs (NSE:AARTIDRUGS) Is Using Debt Reasonably Well
Nov 22We Take A Look At Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Has Earned Their Pay Packet
Aug 28Here's Why We Think Aarti Drugs (NSE:AARTIDRUGS) Is Well Worth Watching
Aug 19Is Aarti Drugs Limited (NSE:AARTIDRUGS) Expensive For A Reason? A Look At Its Intrinsic Value
May 17Here's Why I Think Aarti Drugs (NSE:AARTIDRUGS) Is An Interesting Stock
Apr 04Does Aarti Drugs (NSE:AARTIDRUGS) Have A Healthy Balance Sheet?
Mar 17Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 02What Percentage Of Aarti Drugs Limited (NSE:AARTIDRUGS) Shares Do Insiders Own?
Feb 17Why Aarti Drugs Limited (NSE:AARTIDRUGS) Should Be In Your Dividend Portfolio
Feb 04
What Can We Learn About Aarti Drugs' (NSE:AARTIDRUGS) CEO Compensation?
Jan 22Aarti Drugs' (NSE:AARTIDRUGS) Wonderful 432% Share Price Increase Shows How Capitalism Can Build Wealth
Jan 07If You Like EPS Growth Then Check Out Aarti Drugs (NSE:AARTIDRUGS) Before It's Too Late
Dec 23Aarti Drugs (NSE:AARTIDRUGS) Seems To Use Debt Quite Sensibly
Dec 08Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Nov 23How Much Of Aarti Drugs Limited (NSE:AARTIDRUGS) Do Insiders Own?
Nov 08Here's What We Learned About The CEO Pay At Aarti Drugs Limited (NSE:AARTIDRUGS)
Oct 11Aarti Drugs' (NSE:AARTIDRUGS) Wonderful 514% Share Price Increase Shows How Capitalism Can Build Wealth
Sep 23Aarti Drugs Limited's (NSE:AARTIDRUGS) Business Is Trailing The Market But Its Shares Aren't
Sep 10財務状況分析
短期負債: AARTIDRUGSの 短期資産 ( ₹13.2B ) が 短期負債 ( ₹8.0B ) を超えています。
長期負債: AARTIDRUGSの短期資産 ( ₹13.2B ) が 長期負債 ( ₹3.5B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: AARTIDRUGSの 純負債対資本比率 ( 42.3% ) は 高い と見なされます。
負債の削減: AARTIDRUGSの負債対資本比率は、過去 5 年間で93.3%から44%に減少しました。
債務返済能力: AARTIDRUGSの負債は 営業キャッシュフロー によって 十分にカバー されています ( 63.8% )。
インタレストカバレッジ: AARTIDRUGSの負債に対する 利息支払い は EBIT ( 8 x coverage) によって 十分にカバーされています。